Evidence map›Paper›PMID 36003371›Full record

ArticleFrontiers in immunology2022

Corrigendum: Increased expression of

Marko Manevski, Dinesh Devadoss, Christopher Long, Shashi P Singh, Mohd Wasim Nasser, Glen M Borchert, Madhavan N Nair, Irfan Rahman, Mohan Sopori, Hitendra S Chand

Open access · goldAbstract readPublished Erratum
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 4 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Marko ManevskiDepartment of Immunology and Nano-Medicine, Herbert Wertheim College of Medicine, Florida International University, Miami, FL, United States.
Dinesh DevadossDepartment of Immunology and Nano-Medicine, Herbert Wertheim College of Medicine, Florida International University, Miami, FL, United States.
Christopher LongDepartment of Immunology and Nano-Medicine, Herbert Wertheim College of Medicine, Florida International University, Miami, FL, United States.
Shashi P SinghRespiratory Immunology Program, Lovelace Respiratory Research Institute, Albuquerque, NM, United States.
Mohd Wasim NasserDepartment of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, United States.
Glen M BorchertDepartment of Pharmacology, University of South Alabama, Mobile, AL, United States.
Madhavan N NairDepartment of Immunology and Nano-Medicine, Herbert Wertheim College of Medicine, Florida International University, Miami, FL, United States.
Irfan RahmanDepartment of Environmental Medicine, University of Rochester Medical Center, Rochester, NY, United States.
Mohan SoporiRespiratory Immunology Program, Lovelace Respiratory Research Institute, Albuquerque, NM, United States.
Hitendra S ChandDepartment of Immunology and Nano-Medicine, Herbert Wertheim College of Medicine, Florida International University, Miami, FL, United States.
Florida International University · USLovelace Respiratory Research Institute · USUniversity of Nebraska Medical Center · USUniversity of Rochester Medical Center · USUniversity of South Alabama · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.3389/fimmu.2022.803362.].

Indexed as

bronchial epithelial cellschronic obstructive pulmonary disease (COPD)cigarette smoke (CS)lncRNA antisense to ICAM-1 (LASI)long noncoding RNA (lncRNA)mucus hyperexpression

Identifiers

PMID36003371
PMCPMC9393848
OpenAlexW4290630219

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.